ATE194775T1 - Calcitonin enthaltende pharmazeutische zusammensetzungen - Google Patents

Calcitonin enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE194775T1
ATE194775T1 AT92303554T AT92303554T ATE194775T1 AT E194775 T1 ATE194775 T1 AT E194775T1 AT 92303554 T AT92303554 T AT 92303554T AT 92303554 T AT92303554 T AT 92303554T AT E194775 T1 ATE194775 T1 AT E194775T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
containing calcitonin
calcitonin
calcium deficiency
Prior art date
Application number
AT92303554T
Other languages
English (en)
Inventor
Tudor Arvinte
Amelia Cudd
Judith Phillips
Original Assignee
Novartis Erfind Verwalt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh
Application granted granted Critical
Publication of ATE194775T1 publication Critical patent/ATE194775T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
AT92303554T 1991-04-23 1992-04-21 Calcitonin enthaltende pharmazeutische zusammensetzungen ATE194775T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919108634A GB9108634D0 (en) 1991-04-23 1991-04-23 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE194775T1 true ATE194775T1 (de) 2000-08-15

Family

ID=10693744

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92303554T ATE194775T1 (de) 1991-04-23 1992-04-21 Calcitonin enthaltende pharmazeutische zusammensetzungen

Country Status (19)

Country Link
US (1) US5593962A (de)
EP (1) EP0510913B1 (de)
JP (1) JP3532580B2 (de)
KR (1) KR100245534B1 (de)
AT (1) ATE194775T1 (de)
AU (1) AU653395B2 (de)
CA (1) CA2066532C (de)
CY (1) CY2246B1 (de)
DE (1) DE69231263T2 (de)
DK (1) DK0510913T3 (de)
ES (1) ES2150418T3 (de)
GB (1) GB9108634D0 (de)
GR (1) GR3034414T3 (de)
IE (1) IE921278A1 (de)
IL (1) IL101622A (de)
MX (1) MX9201825A (de)
NZ (1) NZ242440A (de)
PT (1) PT510913E (de)
ZA (1) ZA922899B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595760A (en) * 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions
WO2000054797A2 (en) * 1999-03-17 2000-09-21 Novartis Ag Pharmaceutical compositions comprising tgf-beta
AU783952B2 (en) 2000-02-04 2006-01-05 Unigene Laboratories, Inc. Nasal calcitonin formulations
CN100509053C (zh) 2002-09-27 2009-07-08 赞塔里斯有限公司 持续释放的药物活性肽施用形式及其制备方法
GB0422644D0 (en) * 2004-10-12 2004-11-10 Novartis Ag Organic compounds
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
WO2009125423A2 (en) * 2008-04-07 2009-10-15 National Institute Of Immunology Compositions useful for the treatment of diabetes and other chronic disorder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions

Also Published As

Publication number Publication date
US5593962A (en) 1997-01-14
AU1506692A (en) 1992-10-29
EP0510913A3 (en) 1993-12-15
ES2150418T3 (es) 2000-12-01
DK0510913T3 (da) 2000-10-16
IL101622A0 (en) 1992-12-30
CA2066532C (en) 2003-08-19
MX9201825A (es) 1992-10-01
NZ242440A (en) 1993-10-26
GR3034414T3 (en) 2000-12-29
GB9108634D0 (en) 1991-06-12
CY2246B1 (en) 2003-07-04
KR100245534B1 (ko) 2000-03-02
AU653395B2 (en) 1994-09-29
CA2066532A1 (en) 1992-10-24
EP0510913A2 (de) 1992-10-28
DE69231263T2 (de) 2000-12-21
ZA922899B (en) 1993-10-22
PT510913E (pt) 2000-12-29
IE921278A1 (en) 1992-11-04
IL101622A (en) 1996-06-18
JP3532580B2 (ja) 2004-05-31
JPH05139993A (ja) 1993-06-08
EP0510913B1 (de) 2000-07-19
DE69231263D1 (de) 2000-08-24

Similar Documents

Publication Publication Date Title
DE60018100D1 (en) Polymorphe form von atorvastatin-calcium
MX9204229A (es) Trifluorometilbencilfosfonatos utiles en el tratamiento de osteoporosis.
DE68909691D1 (de) Multischichtkörper zur Abgabe von Duftstoffen.
ATA129892A (de) Pharmazeutische zusammensetzung
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
LV12284A (lv) No kudras izdaliti bioaktivi produkti un tos saturosas farmaceitiskas un kosmetiskas kompozicijas
DE69019363D1 (de) Desinfizierende zusammensetzung und desinfektionsverfahren.
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
IL87421A0 (en) Pharmaceutical compositions containing 5-amino(or substituted amino)-1,2,3-triazoles
SE9802937D0 (sv) Novel compounds
DE3864210D1 (de) Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.
DE69231263D1 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
DE69434210D1 (de) Pharmazeutische antacidzusammensetzung
DE69832722D1 (de) L-threonat-eisen, pharmazeutische zusammensetzung und verwendung zur verbesserung und behandlung von anämie bei menschen
MX9202507A (es) Composicion farmaceutica para el tratamiento de esofagitis de reflujo.
ATE231728T1 (de) Pharmazeutische zusammensetzung enthaltend interferon-gamma stimulatoren
ATE209485T1 (de) Kombinationspräparat enthaltend tramadol und einen calcium-kanal antagonisten
DK0495226T3 (da) Anvendelse af 3-aryl-5-alkylthio-4H-1,2,4-triazoler til behandling af hyperrefleksi som følge af spinaltrauma
PT661058E (pt) Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
DE69003003D1 (de) Pharmazeutische Zusammensetzung.
DE68905343D1 (de) Dosisform zur verabreichung von calciumantagonisten.
ATE86481T1 (de) Dosisform zur verabreichung von calciumantagonisten.
DK0723452T3 (da) Pharmaceutisk antacidsammensætning

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee